1673-422X
2017 Issue 1
Targeting Pyk2 gene on the proliferation,invasion and migration induction of hepatocelluar cancer ;Hep3B cells
Zuo Kai;,Xue Dong;,Kong Li;,Xie Linlin;,Li Wenyu;,Yan Xiaohui;,Xia Xiuliang;
Zuo Kai;,Xue Dong;,Kong Li;,Xie Linlin;,Li Wenyu;,Yan Xiaohui;,Xia Xiuliang;
..............page:1-5
Diagnostic value of combined detection of serum DKK1 and EB virus VCA-IgA for nasopharyngeal car-cinoma
Xu Yiwei;,Huang Lisheng;,Guo Haipeng;,Peng Yuhui;
Xu Yiwei;,Huang Lisheng;,Guo Haipeng;,Peng Yuhui;
..............page:6-10
Expressions and clinical significance of AEG-1 and BECN-1 in papillary thyroid carcinoma
Ren Jia;,Song Ningning;,Wang Xinchao;
Ren Jia;,Song Ningning;,Wang Xinchao;
..............page:11-14
Randomized controlled clinical trial of nedaplatin combined with gemcitabine and cisplatin combined ;with gemcitabine in the treatment of advanced lung squamous cell carcinoma
Zhang Jing;,Chen Qun;,Ke Mingyao;,Zhuang Xibin;,Shi Qin;,Yong Yazhi;,Huang Cheng;
Zhang Jing;,Chen Qun;,Ke Mingyao;,Zhuang Xibin;,Shi Qin;,Yong Yazhi;,Huang Cheng;
..............page:15-18
Association between EGFR mutation status and efficacy of first-line EGFR-TKI in patients with ;advanced non-small cell lung cancer
Jiang Haiying;,Li Yanfang;,Zhu Mei;,Li Qian;,Lyu Jiao;
Jiang Haiying;,Li Yanfang;,Zhu Mei;,Li Qian;,Lyu Jiao;
..............page:19-23
MicroRNAs in exsomes-the new-type of regulatory molecules in the tumor progression
Chen Dayang;,An Fangmei;,Zhan Qiang;
Chen Dayang;,An Fangmei;,Zhan Qiang;
..............page:24-26
Expression and role of Golgi phosphoprotein 3 in cancer
Lin Yanping;,Li Hong;,Shen Lida;
Lin Yanping;,Li Hong;,Shen Lida;
..............page:27-30
Hypoxic tumor microenvironment and immune response
Xiao Junjuan;,Li Yan;,Liang Jing;
Xiao Junjuan;,Li Yan;,Liang Jing;
..............page:31-33
Research of microbiota and tumor immunomodulatory
Xiao Junjuan;,Bi Zhenwang;,Li Yan;
Xiao Junjuan;,Bi Zhenwang;,Li Yan;
..............page:34-37
Nucleic acid aptamer and its research progress in glioma
Kou Zhewen;,Peng Li;,Zhang Xingmei;
Kou Zhewen;,Peng Li;,Zhang Xingmei;
..............page:38-40
Application of bevacizumab for malignant brain edema
Yu Lan;,Zhang Xiaotao;,Liu Li;,Han Xiaona;
Yu Lan;,Zhang Xiaotao;,Liu Li;,Han Xiaona;
..............page:41-44
The application of circulating tumor cells in the diagnosis and treatment of breast cancer
Guan Xiu-wen;,Ma Fei;
Guan Xiu-wen;,Ma Fei;
..............page:45-48
Safety of the nipple-sparing mastectomy in treating breast cancer
Li Wenbin;,Tang Han;,Zou Jieya;,Wang Xiaoqi;,Nie Jianyun;
Li Wenbin;,Tang Han;,Zou Jieya;,Wang Xiaoqi;,Nie Jianyun;
..............page:49-52
Driver genes and targeted drugs in lung cancer
Huang Yan;,Yang Jiyuan;
Huang Yan;,Yang Jiyuan;
..............page:53-56
Appliation of the combination of antiangiogenic agents and EGFR-TKIs in advanced NSCLC treatment
Qu Liyan;,Kang Xiaoyan;,Song Xia;
Qu Liyan;,Kang Xiaoyan;,Song Xia;
..............page:57-59
Therapy for non-small cell lung cancer patients with solitary bone metastases
Dong Yi;,Wei Yuehua;,Hu Weiguo;,Song Qibin;
Dong Yi;,Wei Yuehua;,Hu Weiguo;,Song Qibin;
..............page:60-62
Advances of immune checkpoint blockades in the treatment of digestive cancers
Zhang Zijin;,Ai Bin;
Zhang Zijin;,Ai Bin;
..............page:63-66
The clinical pathological indicators related with prognosis of esophageal squamous cell carcinoma
Rong Lulu;,Xue Liyan;,Lyu Ning;
Rong Lulu;,Xue Liyan;,Lyu Ning;
..............page:67-70
Targeted therapies for gastrointestinal cancer
Huang Yan;,Cheng Dan;,Yang Jiyuan;
Huang Yan;,Cheng Dan;,Yang Jiyuan;
..............page:71-74
The role of microRNA-32 in hepatocarcinoma
Jiang Xiaojia;,Li Shengmian;
Jiang Xiaojia;,Li Shengmian;
..............page:75-77
kai1 cd82 mrna de biao da yu duo yuan fa xing jie zhi chang ai qin xi zhuan yi de guan xi
dong chao ;, xu zheng feng ;, cheng yong ;
dong chao ;, xu zheng feng ;, cheng yong ;
..............page:78-79
yuan fa xing fei dong mai rou liu 1 li
jia xue li ;, zhang wei jing ;, mei zhi hong ;, zhang dao ming ;, zuo wen xing ;
jia xue li ;, zhang wei jing ;, mei zhi hong ;, zhang dao ming ;, zuo wen xing ;
..............page:80-80